IR HOME NEWS & EVENTS OVERVIEW PRESS RELEASES EVENTS & PRESENTATIONS STOCK INFORMATION OVERVIEW HISTORIC STOCK LOOKUP INVESTMENT CALCULATOR ANALYST COVERAGE FINANCIALS & FILINGS OVERVIEW SEC FILINGS CORPORATE GOVERNANCE OVERVIEW LEADERSHIP BOARD OF DIRECTORS COMMITTEE COMPOSITION CONTACT IR IR HOME NEWS & EVENTS OVERVIEW PRESS RELEASES EVENTS & PRESENTATIONS STOCK INFORMATION OVERVIEW HISTORIC STOCK LOOKUP INVESTMENT CALCULATOR ANALYST COVERAGE FINANCIALS & FILINGS OVERVIEW SEC FILINGS CORPORATE GOVERNANCE OVERVIEW LEADERSHIP BOARD OF DIRECTORS COMMITTEE COMPOSITION CONTACT IR Ardelyx Reports First Quarter 2020 Financial Results and Recent Business Highlights Read more about Ardelyx Reports First Quarter 2020 Financial Results and Recent Business Highlights Onaiza Cadoret-Manier Member of the Nominating and Governance Committee Onaiza Cadoret-Manier Ardelyx Appoints Onaiza Cadoret-Manier to its Board of Directors Read more about Ardelyx Appoints Onaiza Cadoret-Manier to its Board of Directors Ardelyx Reports Fourth Quarter and Full Year 2019 Financial Results and Recent Highlights Read more about Ardelyx Reports Fourth Quarter and Full Year 2019 Financial Results and Recent Highlights Ardelyx to Present at the Cowen and Company 40th Annual Health Care Conference Read more about Ardelyx to Present at the Cowen and Company 40th Annual Health Care Conference Ardelyx to Present at the 9th Annual SVB Leerink Global Healthcare Conference Read more about Ardelyx to Present at the 9th Annual SVB Leerink Global Healthcare Conference 2 Cowen-Joseph Thome, Ph.D. Joseph Thome, Ph.D. Cowen Ardelyx Announces Pricing of Upsized Public Offering of Common Stock Read more about Ardelyx Announces Pricing of Upsized Public Offering of Common Stock Ardelyx Announces Proposed Public Offering of Common Stock Read more about Ardelyx Announces Proposed Public Offering of Common Stock Ardelyx Announces Positive Topline Results from Pivotal Phase 3 PHREEDOM Study Evaluating Tenapanor in CKD Patients on Dialysis Read more about Ardelyx Announces Positive Topline Results from Pivotal Phase 3 PHREEDOM Study Evaluating Tenapanor in CKD Patients on Dialysis Pagination First page « First Previous page ‹ Previous … Page 11 Page 12 Page 13 Page 14 Current page 15 Page 16 Page 17 Page 18 Page 19 … Next page Next › Last page Last » Subscribe to FAQs Email Alerts Connect
Ardelyx Reports First Quarter 2020 Financial Results and Recent Business Highlights Read more about Ardelyx Reports First Quarter 2020 Financial Results and Recent Business Highlights
Ardelyx Appoints Onaiza Cadoret-Manier to its Board of Directors Read more about Ardelyx Appoints Onaiza Cadoret-Manier to its Board of Directors
Ardelyx Reports Fourth Quarter and Full Year 2019 Financial Results and Recent Highlights Read more about Ardelyx Reports Fourth Quarter and Full Year 2019 Financial Results and Recent Highlights
Ardelyx to Present at the Cowen and Company 40th Annual Health Care Conference Read more about Ardelyx to Present at the Cowen and Company 40th Annual Health Care Conference
Ardelyx to Present at the 9th Annual SVB Leerink Global Healthcare Conference Read more about Ardelyx to Present at the 9th Annual SVB Leerink Global Healthcare Conference
Ardelyx Announces Pricing of Upsized Public Offering of Common Stock Read more about Ardelyx Announces Pricing of Upsized Public Offering of Common Stock
Ardelyx Announces Proposed Public Offering of Common Stock Read more about Ardelyx Announces Proposed Public Offering of Common Stock
Ardelyx Announces Positive Topline Results from Pivotal Phase 3 PHREEDOM Study Evaluating Tenapanor in CKD Patients on Dialysis Read more about Ardelyx Announces Positive Topline Results from Pivotal Phase 3 PHREEDOM Study Evaluating Tenapanor in CKD Patients on Dialysis